Welcome to the Frontpagehttp://www.bsg.org.uk/index.html
Sat, 10 Dec 2016 05:02:37 +0000Joomla! 1.5 - Open Source Content Managementen-gbNICE committee to develop guidelines on Alcohol: school-based interventionshttp://www.bsg.org.uk/clinical/news/nice-committee-to-develop-guidelines-on-alcohol-school-based-interventions.html
http://www.bsg.org.uk/clinical/news/nice-committee-to-develop-guidelines-on-alcohol-school-based-interventions.htmlNICE are looking to recruit experts on Alcohol to join their Public Health committee to develop a guideline on Alcohol: school-based interventions. They need both lay members (people using services, family members and carers, and members of the public and community or voluntary sector) and people with a professional or practitioner background in the topic.

If any BSG members would like to apply, there are more details on the NICE website. The deadline for applications is 12/01/17 at 17:00.

]]>h.ellison@bsg.org.uk (howard)frontpageTue, 06 Dec 2016 14:15:44 +0000Chair of the Research Advisory Committee on PHE Screeninghttp://www.bsg.org.uk/clinical/news/chair-of-the-research-advisory-committee-on-phe-screening.html
http://www.bsg.org.uk/clinical/news/chair-of-the-research-advisory-committee-on-phe-screening.htmlPublic Health England are currently advertising for three Chairs for Public Health England’s cancer screening programme Research Advisory Committees (RAC). One for each of the below RACs:

Bowel Cancer Screening Programme (BCSP)

Breast Screening Programme (BSP)

Cervical Screening Programme (CSP)

The RACs are responsible for ensuring that PHEs screening programmes support good quality research without compromising the day to day function of the screening programmes. Candidates should be able to demonstrate experience in one or more of the following:

Experience in chairing a multidisciplinary group.

A detailed understanding of screening.

Experience in health services research (ideally in screening programmes).

]]>h.ellison@bsg.org.uk (howard)frontpageThu, 01 Dec 2016 13:27:47 +0000Sir Francis Avery-Jones BSG Research Award 2017http://www.bsg.org.uk/research/news/sir-francis-avery-jones-bsg-research-award-2017.html
http://www.bsg.org.uk/research/news/sir-francis-avery-jones-bsg-research-award-2017.htmlApplications are invited by the Research Committee of the British Society of Gastroenterology and must include:

One A4 page ONLY describing the work conducted.

A bibliography of relevant personal publications.

The title and an outline of the proposed content of the lecture.

A written statement confirming that all or a substantial part of the work has been personally conducted by the applicant in the UK or Eire.

A written statement confirming that the applicant will be aged 40 years or less OR will have held a Consultant/Honorary Consultant post for less than 5 years (or whole-time equivalent if part time or in intermittent employment) on the date of the lecture.

Entrants need not be a member of the Society.

The recipient will be required to deliver a 20-minute lecture during the plenary session at BSG 2017, which will be held on Tuesday 20 June 2017 at the Manchester Central Convention Complex. The winner will be entitled to full registration for the whole meeting (19-22 June 2017) and to travel and accommodation expenses as specified in their speaker entitlement letter.

Applications should be composed electronically in Word or PDF format and emailed as an attachment to the BSG Office (research@bsg.org.uk) with the email subject line "Avery-Jones BSG Research Award 2017" by 5.00pm on Monday 20 February 2017. Applicants will be notified of the decision by 10 March 2017, a week before the early bird registration deadline.

]]>j.solomon@bsg.org.uk (Julie Solomon)frontpageTue, 29 Nov 2016 13:47:56 +0000Graham Bull prize in clinical science and Goulstonian Lectureship 2017http://www.bsg.org.uk/clinical/news/graham-bull-prize-in-clinical-science-and-goulstonian-lectureship-2017.html
http://www.bsg.org.uk/clinical/news/graham-bull-prize-in-clinical-science-and-goulstonian-lectureship-2017.htmlThe Graham Bull prize was established in 1988 in honour of Sir Graham Bull, who was the first director of the Clinical Research Centre at Northwick Park. A trust for the Graham Bull prize was set up to provide money for young research workers under the age of 45 who feel that they have made a major contribution to clinical science.

The prize as designed by the trust is specifically for an application and not for nomination of individuals. The work can cover a wide range of expertise, such as:

molecular and cellular biology

imaging technology

psychiatry

health sciences

The award is open to RCP members and fellows who must apply for their own work to be considered. The sum of £1,000 is offered on a competitive basis each year.

The winner of this prize will be invited to deliver the Goulstonian Lecture, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband, Dr Theodore Goulston FRCP.

Researchers must be under the age of 45 on the application closing date (as per the terms of the original bequest), and must be a member or fellow of RCP London.

Further information, including details of how to apply, may be found on the RCP website:

The BSG has been actively engaging with NHS England on behalf of members around proposals for a Best Practice Tariff (BPT) for lower GI endoscopy through a Straight To Test (STT) pathway. As a result of these discussions a position statement was agreed to both support members locally and put forward the views of the Society to the consultation process around the proposed BPT. In any consideration of a STT pathway, be it with managers or commissioners/payers) for lower GI endoscopy members are urged to have regard for the points made in the statement to ensure patients receive the best possible care and resources are used effectively. While the specifics of the tariff relate to colleagues in England the same issues should be considered in all UK systems.

]]>h.ellison@bsg.org.uk (howard)frontpageMon, 07 Nov 2016 13:20:56 +0000BSG guidance on the use of faecal calprotectin testing in IBDhttp://www.bsg.org.uk/clinical-guidance/ibd/bsg-guidance-on-the-use-of-faecal-calprotectin-testing-in-ibd.html
http://www.bsg.org.uk/clinical-guidance/ibd/bsg-guidance-on-the-use-of-faecal-calprotectin-testing-in-ibd.htmlUpdated guidance document on use of faecal calprotectin – both in assessment of GI symptoms, and also in patients with known IBD.

Dr Barney Hawthorne, Chair BSG IBD Section Committee, October 2016.

Differentiation between inflammatory bowel disease (IBD) and functional gut disorders, and the determination of mucosal disease activity in established cases of IBD remain the cornerstones of disease diagnosis and management. Non-invasive, accurate biomarkers of gut inflammation are needed due to the variability of symptoms, the inaccuracies of currently available blood markers and the cost and invasive nature of endoscopy. Numerous biomarkers have been used and/or considered with some in current use...

]]>h.ellison@bsg.org.uk (howard)frontpageTue, 01 Nov 2016 13:24:08 +0000Core announces two research fellowshipshttp://www.bsg.org.uk/research/news/core-announces-two-research-fellowships.html
http://www.bsg.org.uk/research/news/core-announces-two-research-fellowships.htmlCore has two substantial 3-year fellowship opportunities that are available only once every three years. If you’re interested in carrying out research on the oesophagus, stomach or duodenum, don’t miss out on the Core Derek Butler Fellowship. If you're interested in pancreatic inflammation or injury, the Core Amelie Waring Fellowship is the one for you. Core – fighting digestive diseases through research.]]>h.ellison@bsg.org.uk (howard)frontpageMon, 26 Sep 2016 12:28:02 +0000BSG Statement on the findings of the IBD Audit Reporthttp://www.bsg.org.uk/clinical/news/bsg-statement-on-the-findings-of-the-ibd-audit-report.html
http://www.bsg.org.uk/clinical/news/bsg-statement-on-the-findings-of-the-ibd-audit-report.htmlCommenting, Dr Barney Hawthorne, Chairman of the IBD Section at the BSG, said:

"The British Society of Gastroenterology (BSG) welcomes the findings of the latest round of the UK IBD Audit published today by the Royal College of Physicians, particularly noting the data on the use of biosimilar versions of infliximab in the NHS, and welcomes the contribution of BSG members to the findings.

"In February this year the BSG has published a guidance document supporting their use in IBD patient care. The guidance advocates their use when prescribed by brand name, and emphasises the importance of ongoing pharmacovigilance for patients receiving these drugs through ongoing data collection through the UK IBD Registry.

"With the NHS facing significant increasing financial pressures, biosimilars contribute towards improving IBD patient care and outcome while creating efficiency savings of up to £3million annually in this therapeutic area alone. We are encouraged by the reports key findings, including biosimilar versions of infliximab being shown to be as effective as other originator versions. It is vital that the reductions in costs to the NHS are used to reinvest in improvements to IBD services.

"The BSG have worked hard with partners to develop a wider IBD programme in the UK – encompassing the IBD Audit, BSG’s IBD Registry and IBD Standards – and hope that this collaboration will continue to benefit patients with IBD."

Frontline Gastroenterology prize (£250) for the best patient benefit in gastroenterology oral communication: OC-038 (Making the change: switching to infliximab biosimilars for IBD at North Bristol NHS Trust), presented by Louise Chung during the Gastroenterology Service Free Papers session.

BMJ Open Gastroenterology prize (article processing is free for one submission) for the best clinical science oral communication: OC-017 (international multicentre study assessing the effects of anti-thrombotic use in patients with upper GI bleeding), presented by Philip Dunne during the Gastroduodenal Free Papers session

]]>h.ellison@bsg.org.uk (howard)frontpageWed, 06 Jul 2016 12:02:49 +0000Conference Report: Improving Outcomes for Gastrointestinal Cancer in the UK http://www.bsg.org.uk/clinical/news/conference-report-improving-outcomes-for-gastrointestinal-cancer-in-the-uk.html
http://www.bsg.org.uk/clinical/news/conference-report-improving-outcomes-for-gastrointestinal-cancer-in-the-uk.htmlOn 7 December 2015, the British Society of Gastroenterology and the Royal College of Physicians held a joint conference: GI cancer in the UK: can we do better? The meeting was timely as, although outcomes for patients with most gastrointestinal cancers in the UK have steadily improved in the past 10 years, survival figures remain substantially worse than in many other comparable nations.

An extensive write up of the meeting, covering screening, early diagnosis, specific tumour sites and the interface between primary and secondary care were covered by leading UK experts.

This has been published in Frontline Gastroenterology and can be access through the link below.